Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

A combined PET-MRI scan could improve treatment for patients with early breast cancer

Dr Rosa Di Micco - San Raffaele Hospital, Milan, Italy
A combined PET-MRI scan could improve treatment for patients with early breast cancer ( Dr Rosa Di Micco - San Raffaele Hospital, Milan, Italy )
26 Apr 2024

EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer

Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium)
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024

Comment: EBCC 2024 highlights

Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium)
Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )
24 Apr 2024

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma

Dr Sundar Jagannath - Icahn School of Medicine at Mount Sinai, New York, USA
Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multiple myeloma ( Dr Sundar Jagannath - Icahn School of Medicine at Mount Sinai, New York, USA )
24 Apr 2024

Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer

Dr Sujit Nair - Icahn School of Medicine at Mount Sinai, New York, USA
Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer ( Dr Sujit Nair - Icahn School of Medicine at Mount Sinai, New York, USA )
24 Apr 2024

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures

Prof Antoine Italiano - Institute Bergonié, Bordeaux, France
Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures ( Prof Antoine Italiano - Institute Bergonié, Bordeaux, France )
24 Apr 2024

Do patients and doctors treatment aspirations align? KCCure survey – part A

Prof Michael Staehler and Dena Battle
Do patients and doctors treatment aspirations align? KCCure survey – part A ( Prof Michael Staehler and Dena Battle )
23 Apr 2024

Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC

Prof Bertrand Tombal - Université Catholique de Louvain, Brussels, Belgium
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC ( Prof Bertrand Tombal - Université Catholique de Louvain, Brussels, Belgium )
16 Apr 2024

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy

Dr Pasi A. Jänne - Dana-Farber Cancer Institute, Boston, USA
Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy ( Dr Pasi A. Jänne - Dana-Farber Cancer Institute, Boston, USA )
12 Apr 2024

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

Dr Rebecca Porter - Dana-Farber Cancer Institute, Boston, USA
Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype ( Dr Rebecca Porter - Dana-Farber Cancer Institute, Boston, USA )
12 Apr 2024

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark
Urinary markers in the surveillance setting of non-muscle invasive bladder cancer ( Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark )
10 Apr 2024